BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17379424)

  • 1. Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer.
    Wang Z; Ma Q
    Med Hypotheses; 2007; 69(4):816-20. PubMed ID: 17379424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of SDF-1 and its receptor CXCR4 in tumor metastasis].
    Chen H; Tan Y; Cai S; Ma W; Guo Z; Du J; Cai S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1180-3. PubMed ID: 18027722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
    Kucia M; Reca R; Miekus K; Wanzeck J; Wojakowski W; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
    Stem Cells; 2005 Aug; 23(7):879-94. PubMed ID: 15888687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CXCL12 in metastasis of human ovarian cancer.
    Jiang YP; Wu XH; Xing HY; DU XY
    Chin Med J (Engl); 2007 Jul; 120(14):1251-5. PubMed ID: 17697577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
    Sutton A; Friand V; Brulé-Donneger S; Chaigneau T; Ziol M; Sainte-Catherine O; Poiré A; Saffar L; Kraemer M; Vassy J; Nahon P; Salzmann JL; Gattegno L; Charnaux N
    Mol Cancer Res; 2007 Jan; 5(1):21-33. PubMed ID: 17259344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.
    Dewan MZ; Ahmed S; Iwasaki Y; Ohba K; Toi M; Yamamoto N
    Biomed Pharmacother; 2006 Jul; 60(6):273-6. PubMed ID: 16828253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer.
    Saur D; Seidler B; Schneider G; Algül H; Beck R; Senekowitsch-Schmidtke R; Schwaiger M; Schmid RM
    Gastroenterology; 2005 Oct; 129(4):1237-50. PubMed ID: 16230077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
    Shim H; Lau SK; Devi S; Yoon Y; Cho HT; Liang Z
    Biochem Biophys Res Commun; 2006 Jul; 346(1):252-8. PubMed ID: 16756955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
    Zeelenberg IS; Ruuls-Van Stalle L; Roos E
    Cancer Res; 2003 Jul; 63(13):3833-9. PubMed ID: 12839981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal cell-derived factor-1 (SDF-1)\CXCR4 couple plays multiple roles on haematopoietic progenitors at the border between the old cytokine and new chemokine worlds: survival, cell cycling and trafficking.
    Lataillade JJ; Domenech J; Le Bousse-Kerdilès MC
    Eur Cytokine Netw; 2004; 15(3):177-88. PubMed ID: 15542441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability.
    Chu H; Zhou H; Liu Y; Liu X; Hu Y; Zhang J
    Int J Biochem Cell Biol; 2007; 39(1):197-205. PubMed ID: 16973405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
    Wang J; Loberg R; Taichman RS
    Cancer Metastasis Rev; 2006 Dec; 25(4):573-87. PubMed ID: 17165132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
    Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
    Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
    Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line.
    Porcile C; Bajetto A; Barbero S; Pirani P; Schettini G
    Ann N Y Acad Sci; 2004 Dec; 1030():162-9. PubMed ID: 15659794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer.
    Eisenhardt A; Frey U; Tack M; Rosskopf D; Lümmen G; Rübben H; Siffert W
    Eur Urol; 2005 Jan; 47(1):111-7. PubMed ID: 15582259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma.
    Tucci MG; Lucarini G; Brancorsini D; Zizzi A; Pugnaloni A; Giacchetti A; Ricotti G; Biagini G
    Br J Dermatol; 2007 Dec; 157(6):1212-6. PubMed ID: 17970806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.